Effects of Glutamine in Ischemic Heart Disease Patients Following Cardiopulmonary Bypass
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether perioperative glutamine administration
possess protective properties on internal organs (heart and gut) in patients with coronary
atherosclerosis, operated under cardiopulmonary bypass.
Phase:
Phase 3
Details
Lead Sponsor:
Meshalkin Research Institute of Pathology of Circulation